Recent News and Articles on the Keywords: liver + breakthrough + treatment  Related to the article below (Last Update: 8/5/2008)

World-First Breakthrough for Women's Sexual Satisfaction MarketWatch - Jul 31, 2008 SYDNEY, Jul 31, 2008 (BUSINESS WIRE) -- Australian pharmacists believe they have developed a technology breakthrough in the treatment of women who ... Vertex Pharmaceuticals Highlights Telaprevir Progress and Reports ... MarketWatch - Jul 31, 2008 This response appears to have been maintained, with no viral breakthrough observed to date among 36 patients who had completed 4 weeks of treatment, ...VRTX Oneindia Cystic Fibrosis Treatment Expected Oneindia, India - Aug 1, 2008 Cystic fibrosis (also known as CF, mucoviscoidosis, or mucoviscidosis) is a hereditary disease that affects the exocrine (mucus) glands of the lungs, liver, ... Jennerex Publishes Clinical Trial Data With Lead Product JX-594 ... MarketWatch - Jul 22, 2008 As previously reported, 14 patients with a variety of treatment-refractory cancer types (eg liver, colon, lung) in the liver were treated every three weeks ...SEO:006280 - OTC:CMTX Raptor Pharmaceuticals Enters Collaboration Agreement with UC San ... MarketWatch - Jul 16, 2008 NASH is a progressive form of liver disease that accounts for approximately 10% of newly diagnosed cases of chronic liver disease, and ranks as one of the ... Raptor Pharmaceuticals Expands Board of Directors and Scientific ... FOXBusiness all 33 news articles »  OTC:RPTP - OTC:CMTX Breakthrough In Bone Cancer Treatment Central Florida News 13|, FL - Jul 17, 2008 Debbie still has cancer in her lungs and liver, but even that has gone down as well. She just had her three month checkup report and found the tumor is ... Organic 'dye' used in melanoma treatment ABC Online, Australia - Jul 22, 2008 MARK COLVIN: An organic compound used by Indian women to paint red dots on their foreheads could hold the key to a breakthrough in cancer treatment. ... Hope for Advanced Liver Cancer Ivanhoe, FL - Jul 24, 2008 (Ivanhoe Newswire) -- There may be new hope for those suffering with advanced liver cancer, a disease with no effective treatment. ... Therapy helps children at risk for post-transplant ... Science Centric, Bulgaria - Aug 1, 2008 The antiviral drug, valganciclovir, can lower the levels of Epstein-Barr virus in children with liver transplants, according to a new study. ... Raptor Pharmaceuticals Enters Collaboration Agreement with UC San ... CNW Telbec (Communiqu?s de presse), Canada - Jul 16, 2008 NASH is a progressive form of liver disease that accounts for approximately 10% of newly diagnosed cases of chronic liver disease, and ranks as one of the ...OTC:RPTP

Liver: Breakthrough made in treatment

A breakthrough in Acute Liver Failure (ALF) treatment, developed by an Indo-Japan joint research project, was presented at the recently concluded 4th Annual meeting of the International Society for Stem Cells Research, held at Toronto, Canada. Well received and acclaimed by more than two thousand participants of the conference, the presentation on the novel method for treating acute liver failure made by Dr C M Habibullah of the Centre for Liver Research and Diagnosis, (CLRD) and Dr Samuel JK Abraham of Nichi-In Centre for Regenerative Medicine (NCRM), an Indo-Japan joint venture institute based at Chennai, caught the attention of the stem cell research community all over the world.

        Acute Liver Failure (ALF) affect thousands of patients in India every year, and there has been no definitive treatment available for such conditions except a temporary rescue procedure which is available only in a handful of centres in the country or the orthotopic liver transplantation, which is highly technical and very expensive, yet giving only a 60 per cent success rate.

        The team came out with an idea of using the foetal liver (taken from aborted fetuses) in treating the diseases with successful outcome. But due to shortage of the foetal liver, the team stumbled upon a novel approach of using TGP encapsulated hepatocytes to overcome that obstacle. 'We have proven that the expansion of the foetal liver substance in vitro (in the laboratory) and prolonging its life and functional capability in vivo (inside the body) is possible using our technology in animal models. When this same principle can be applied to patients, this could save thousands of patients in India who suffer from Acute Liver Failure, if they come to the hospital early', says Dr Samuel JK Abraham, Director of NCRM.

        The team's research revealed that acute liver failure could be treated much effectively using hepatocytes encapsulated in a Thermoreversible Gelation Polymer. The Thermogelation Polymer based cell culture technology, developed by Yuichi Mori and Dr Hiroshi Yoshioka - both from Waseda University, Tokyo, Japan, was applied in this research.

        This is the first time in the world that a non biological (totally synthetic) material was used as a substrate to grow (cultivate) human foetal hepatic cells, cell lines and tissues including stem cells thereby paving a way for avoiding biological materials for this purpose and avoiding viral and other dangerous known and unknown contaminations in such biological materials as well as chances of rejections.